Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012287
Palm, D. Pereyaslov, D. Vaz, J. Broberg, E. Zeller, H. Gross, D. Brown, C.S. Struelens, M.
Palm, D.
Pereyaslov, D.
Vaz, J.
Broberg, E.
Zeller, H.
Gross, D.
Brown, C.S.
Struelens, M.
Citations
Altmetric:
Abstract
A rapid survey by the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) Regional Office for Europe ascertained the availability of national reference laboratory testing for a recently detected novel coronavirus as of 28 November 2012. Screening by internal quality controlled upE-RT-PCR assay was available in 23/46 of responding countries in the WHO European Region, of which 19/30 in European Union (EU) and European Economic Area (EEA) countries. Confirmation of positive screened samples by either ORF1b - RT-PCR, or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis was available in 22/46 responding countries of which 18/30 in EU/EEA countries
Description
Date
2012-12-06
Journal Title
Journal ISSN
Volume Title
Publisher
Chapter title
Publication type
Peer reviewed scientific article
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
2012, analysi, analysis, Area, article, AS, Control, Coronavirus, Coronavirus Infections, Countries, detection, Diagnosis, disease, ecdc, ECONOMIC, electronic, EU, Europe, European, European Union, genetics, health, Humans, im, IS, isolation & purification, journal, Laboratories, methods, Molecular, molecular detection, national, organization, prevention, Quality, Reference Standards, region, regional, Reverse Transcriptase Polymerase Chain Reaction, Rna, Rna,Viral, Sample, Samples, SB - IM, SCREENING, Sequence Analysis, standards, survey, Sweden, Target, TESTING, virology, WHO, whole genome, world, World Health, World Health Organization, World-health-organization